New Delhi: Come May 1, the COVID-19 vaccination drive will be prolonged to everybody above the age of 18, a step that has been taken by the Centre to make sure that most numbers of Indians take the coronavirus vaccine jab amid the raging second wave of the pandemic.
The phase-III of the world’s largest COVID-19 vaccination drive additionally goals at liberalised vaccine pricing and scaling up of vaccine protection.
Phase-I used to be launched on January 16, 2021, which prioritized the safety of the Health Care Workers (HCWs) and Front Line Workers (FLWs).
Subsequently, phase-II was initiated from March 1 and April 1, which targeted on defending essentially the most susceptible, ie, all folks above 45 years of age.
In India, the Emergency Use Authorisation has thus far been granted to 2 indigenously manufactured vaccines – COVISHEILD of Serum Institute of India and COVAXIN of Bharat Biotech, On the opposite hand, a 3rd vaccine, Sputnik, which is presently manufactured overseas, will ultimately be manufactured in India.
Know the costs of COVISHEILD and COVAXIN photographs in authorities hospitals
The Serum Institute of India COVID-19 vaccine COVISHEILD will be out there for Rs 400/dose in State Government hospitals, whereas, Bharat Biotech’s COVID-19 vaccine COVAXIN will cost you Rs 600 per dose in State Government hospitals.
Know the costs of COVISHEILD and COVAXIN photographs in personal hospitals
The COVISHEILD COVID-19 vaccine has been capped at Rs 600/dose in personal hospitals, whereas a single shot of the COVAXIN coronavirus vaccine will cost you Rs 1,200 in personal hospitals.
Meanwhile, the Ministry of Health and Family Welfare on Saturday (April 24, 2021) introduced that India has change into the quickest nation to manage 14 crore Doses of the COVID-19 vaccine. The milestone has been achieved in simply 99 days, the place the cumulative variety of coronavirus vaccine doses administered within the nation stands at 14,08,02,794.
